Tokyo Tape
Sign in
← Koa Shoji Holdings

Quarterly report · Q1

9273.TEDINET S100SAN2
Period2023-07-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥5.8bn2023-07-01 → 2023-09-30Cons.Net sales
Revenue¥22.1bn2022-07-01 → 2023-06-30Cons.Net sales (5-year summary)
Revenue¥5.4bn2022-07-01 → 2022-09-30Cons.Net sales
Operating income¥1.2bn2023-07-01 → 2023-09-30Cons.Operating income
Operating income¥1.0bn2022-07-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.2bn2023-07-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥4.1bn2022-07-01 → 2023-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥979m2022-07-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.2bn2023-07-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥979m2022-07-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥758m2023-07-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.7bn2022-07-01 → 2023-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥606m2022-07-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥758m2023-07-01 → 2023-09-30Cons.Profit loss
Net income¥606m2022-07-01 → 2022-09-30Cons.Profit loss
Total assets¥28.7bnat 2023-09-30Cons.Assets
Total assets¥28.5bnat 2023-06-30Cons.Assets
Total assets¥26.3bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥7.4bnat 2023-09-30Cons.Liabilities
Total liabilities¥7.5bnat 2023-06-30Cons.Liabilities
Net assets / equity¥21.2bnat 2023-09-30Cons.Net assets
Net assets / equity¥20.9bnat 2023-06-30Cons.Net assets
Net assets / equity¥18.8bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥9.6bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥10.8bnat 2023-06-30Cons.Cash and deposits
EPS (basic)¥19.122023-07-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥67.832022-07-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥15.292022-07-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio74.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio73.5%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio71.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-09-30−¥449m
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-09-30−¥449m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-09-30−¥15m
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue2023-07-01 → 2023-09-30¥4.0bn
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue external2023-07-01 → 2023-09-30¥3.6bn
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue intersegment2023-07-01 → 2023-09-30¥449m
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentsegment profit2023-07-01 → 2023-09-30¥686m
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue2023-07-01 → 2023-09-30¥2.2bn
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue external2023-07-01 → 2023-09-30¥2.2bn
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentsegment profit2023-07-01 → 2023-09-30¥526m
—segment totalrevenue2023-07-01 → 2023-09-30¥6.3bn
—segment totalrevenue external2023-07-01 → 2023-09-30¥5.8bn
—segment totalrevenue intersegment2023-07-01 → 2023-09-30¥449m
—segment totalsegment profit2023-07-01 → 2023-09-30¥1.2bn
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30−¥501m
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-09-30−¥501m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30¥6m
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue2022-07-01 → 2022-09-30¥4.0bn
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue external2022-07-01 → 2022-09-30¥3.5bn
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥501m
jpcrp040300-q1r_E34071-000Drug Substance Sales Businessreportable segmentsegment profit2022-07-01 → 2022-09-30¥672m
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue2022-07-01 → 2022-09-30¥1.9bn
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentrevenue external2022-07-01 → 2022-09-30¥1.9bn
jpcrp040300-q1r_E34071-000Pharmaceutical Marketing Businessreportable segmentsegment profit2022-07-01 → 2022-09-30¥337m
—segment totalrevenue2022-07-01 → 2022-09-30¥5.9bn
—segment totalrevenue external2022-07-01 → 2022-09-30¥5.4bn
—segment totalrevenue intersegment2022-07-01 → 2022-09-30¥501m
—segment totalsegment profit2022-07-01 → 2022-09-30¥1.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 346
ItemContextValueUnit
Deferred tax assetsPrior1YearInstant222079000JPY
Deferred tax assetsCurrentQuarterInstant205596000JPY
Net defined benefit assetPrior1YearInstant29891000JPY
Net defined benefit assetCurrentQuarterInstant29528000JPY
Other ioaPrior1YearInstant15652000JPY
Other ioaCurrentQuarterInstant16280000JPY
Investments and other assetsPrior1YearInstant324399000JPY
Investments and other assetsCurrentQuarterInstant322778000JPY
Noncurrent assetsPrior1YearInstant6634234000JPY
Noncurrent assetsCurrentQuarterInstant6797421000JPY
AssetsPrior1YearInstant28464493000JPY
AssetsCurrentQuarterInstant28654702000JPY
Notes and accounts payable tradePrior1YearInstant1504004000JPY
Notes and accounts payable tradeCurrentQuarterInstant1808015000JPY
Electronically recorded obligations operating clPrior1YearInstant686818000JPY
Electronically recorded obligations operating clCurrentQuarterInstant947593000JPY
Short term loans payablePrior1YearInstant850000000JPY
Short term loans payableCurrentQuarterInstant850000000JPY
Current portion of long term loans payablePrior1YearInstant349904000JPY
Current portion of long term loans payableCurrentQuarterInstant373904000JPY
Income taxes payablePrior1YearInstant810011000JPY
Income taxes payableCurrentQuarterInstant426779000JPY
Provision for bonusesPrior1YearInstant48558000JPY
Provision for bonusesCurrentQuarterInstant114103000JPY
Other clPrior1YearInstant984618000JPY
Other clCurrentQuarterInstant684149000JPY
Current liabilitiesPrior1YearInstant5233914000JPY
Current liabilitiesCurrentQuarterInstant5204546000JPY
Long term loans payablePrior1YearInstant1941288000JPY
Long term loans payableCurrentQuarterInstant1869288000JPY
Deferred tax liabilitiesPrior1YearInstant1460000JPY
Deferred tax liabilitiesCurrentQuarterInstant3787000JPY
Provision for directors retirement benefitsPrior1YearInstant137624000JPY
Provision for directors retirement benefitsCurrentQuarterInstant140637000JPY
Net defined benefit liabilityPrior1YearInstant135597000JPY
Net defined benefit liabilityCurrentQuarterInstant141652000JPY
Other nclPrior1YearInstant91119000JPY
Other nclCurrentQuarterInstant82937000JPY
Noncurrent liabilitiesPrior1YearInstant2307090000JPY
Noncurrent liabilitiesCurrentQuarterInstant2238302000JPY
LiabilitiesPrior1YearInstant7541004000JPY
LiabilitiesCurrentQuarterInstant7442849000JPY
Capital stockPrior1YearInstant522277000JPY
Capital stockCurrentQuarterInstant522277000JPY
Capital surplusPrior1YearInstant205828000JPY
Capital surplusCurrentQuarterInstant205828000JPY
Retained earningsPrior1YearInstant20172089000JPY
Retained earningsCurrentQuarterInstant20454252000JPY
Treasury stockPrior1YearInstant-407000JPY
Treasury stockCurrentQuarterInstant-407000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-06-30pass rounding
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-07-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-06-30pass
statement vs summary · total assetsconsolidated 2023-09-30pass